{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:09:38Z","timestamp":1770905378510,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.vaccine.2024.01.066","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T12:11:29Z","timestamp":1706184689000},"page":"1195-1199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5136-4208","authenticated-orcid":false,"given":"Azwidihwi","family":"Takalani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phumeza","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Bodenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vuyelo","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vernon","family":"Louw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Opie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonny","family":"Peter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Rowji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishen","family":"Seocharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarylee","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla","family":"Yende-Zuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentse","family":"Khutho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Sanne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda-Gail","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenda","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameena","family":"Goga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.01.066_b0005","doi-asserted-by":"crossref","unstructured":"Takuva S, Takalani A, Seocharan I, Yende-Zuma N, Reddy T, Engelbrecht I, et al. Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial. Suthar AB, editor. PLOS Med. 2022 Jun 21;19(6):e1004024.","DOI":"10.1371\/journal.pmed.1004024"},{"issue":"10330","key":"10.1016\/j.vaccine.2024.01.066_b0010","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S0140-6736(22)00007-1","article-title":"Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study","volume":"399","author":"Bekker","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.01.066_b0015","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc2202061","article-title":"Effectiveness of Ad26.COV2.S and BNT162b2 vaccines against omicron variant in South Africa","author":"Gray","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.vaccine.2024.01.066_b0020","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jacig.2021.12.002","article-title":"Allergic reactions to the Ad26.COV2.S vaccine in South Africa","volume":"1","author":"Peter","year":"2022","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"6","key":"10.1016\/j.vaccine.2024.01.066_b0025","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMc2107920","article-title":"Thromboembolic events in the South African Ad26.COV2.S vaccine study","volume":"385","author":"Takuva","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.01.066_b0030","unstructured":"Johnson and Johnson. Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S. [Internet]. 2021. Available from: https:\/\/www.jnj.com\/johnson-johnson-announces-real-world-evidence-and-phase-3-data-confirming-strong-and-long-lasting-protection-of-single-shot-covid-19-vaccine-in-the-u-s."},{"issue":"12","key":"10.1016\/j.vaccine.2024.01.066_b0035","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S1473-3099(22)00506-0","article-title":"Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"22","author":"Hardt","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.01.066_b0040","unstructured":"Penny M. Heaton. Booster Dose of Janssen COVID-19 Vaccine (Ad26.COV2.S) Following Primary Vaccination [Internet]. Advisory Committee on Immunization Practices; 2021 Oct 21 [cited 2022 Jul 2]. <https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-10-20-21\/03-covid-heaton-douoguih-508.pdf>."},{"key":"10.1016\/j.vaccine.2024.01.066_b0045","unstructured":"World Health Organization. Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine [Internet]. World Health Organization; 2021 [cited 2022 Jul 2]. <https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE-recommendation-Ad26.COV2.S-2021.1>."},{"issue":"12","key":"10.1016\/j.vaccine.2024.01.066_b0050","article-title":"Pathogenic mechanisms of vaccine-induced immune thrombotic thrombocytopenia in people receiving anti-COVID-19 adenoviral-based vaccines: a proposal","volume":"13","author":"Azzarone","year":"2021","journal-title":"Front Immunol"},{"issue":"7873","key":"10.1016\/j.vaccine.2024.01.066_b0055","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/d41586-021-02291-2","article-title":"COVID vaccines and blood clots: what researchers know so far","volume":"596","author":"Ledford","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.01.066_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102742","article-title":"Cardiovascular, neurological, and pulmonary events following vaccination with the BNT162b2, ChAdOx1 nCoV-19, and Ad26.COV2.S vaccines: an analysis of European data","volume":"125","author":"Cari","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2024.01.066_b0065","series-title":"South African National Department of Health","author":"South African Health Products Regulatory Authority","year":"2020"},{"key":"10.1016\/j.vaccine.2024.01.066_b0070","unstructured":"BRighton Collaboration. Safety Platform for Emergency vACcines (SPEAC). The Task Force for Global Health."},{"key":"10.1016\/j.vaccine.2024.01.066_b0075","unstructured":"Discovery Health Medical Scheme. Deep venous thrombosis and pulmonary embolism rates, South Africa. 2019."},{"key":"10.1016\/j.vaccine.2024.01.066_b0080","doi-asserted-by":"crossref","unstructured":"Burn E, Li X, Kostka K, Stewart HM, Reich C, Seager S, et al. Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID \u201019 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf. 2022 May;31(5):495\u2013510.","DOI":"10.1002\/pds.5419"},{"key":"10.1016\/j.vaccine.2024.01.066_b0085","doi-asserted-by":"crossref","unstructured":"Gray GE, Collie S, Garrett N, Goga A, Champion J, Zylstra M, et al. Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study [Internet]. Infectious Diseases (except HIV\/AIDS); 2021 Dec [cited 2022 Mar 30]. <http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.12.28.21268436>.","DOI":"10.1101\/2021.12.28.21268436"},{"issue":"5","key":"10.1016\/j.vaccine.2024.01.066_b0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.01.066_b0095","doi-asserted-by":"crossref","first-page":"e2023006","DOI":"10.4178\/epih.e2023006","article-title":"Self-reported Adverse events following the second dose of COVID-19 Vaccines in the Republic of Korea: recipient survey, February to December 2021","volume":"26","author":"Kwon","year":"2022","journal-title":"Epidemiol Health"},{"issue":"3","key":"10.1016\/j.vaccine.2024.01.066_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.15585\/mmwr.mm7103a4","article-title":"Use of the Janssen (Johnson & Johnson) COVID-19 vaccine: updated interim recommendations from the advisory committee on immunization practices \u2014 United States, December 2021","volume":"71","author":"Oliver","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2024.01.066_b0105","article-title":"Guillain-Barr\u00e9 syndrome after Ad26.COV2.S vaccination","volume":"23","author":"Thant","year":"2022","journal-title":"Am J Case Rep [Internet]"},{"key":"10.1016\/j.vaccine.2024.01.066_b0110","doi-asserted-by":"crossref","unstructured":"Woo EJ, Mba-Jonas A, Dimova RB, Alimchandani M, Zinderman CE, Nair N. Association of Receipt of the Ad26.COV2.S COVID-19 Vaccine With Presumptive Guillain-Barr\u00e9 Syndrome, February-July 2021. JAMA. 2021 Oct 26;326(16):1606.","DOI":"10.1001\/jama.2021.16496"},{"key":"10.1016\/j.vaccine.2024.01.066_b0115","unstructured":"World Health Organisation Technical Report Series. Causality Assessment of an adverse event following immunization [Internet]. 2019 [cited 2023 Dec 13]. Available from: iris.who.int."},{"key":"10.1016\/j.vaccine.2024.01.066_b0120","article-title":"COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): a systematic review and post hoc analysis","volume":"27","author":"Hafeez","year":"2021","journal-title":"Clin Appl Thromb"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:34:15Z","timestamp":1759404855000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24000781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0264410X24000781"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.01.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}